(Q37117133)

English

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole (English)

1 reference

Europe PubMed Central

18 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Gaëtan MacGrogan

8

object named as

Gaëtan MacGrogan

0 references

Wojciech P Olszewski

object named as

Wojciech P Olszewski

13

0 references

Mauro Giuseppe Mastropasqua

object named as

Mauro G Mastropasqua

5

0 references

Eugenio Maiorano

object named as

Eugenio Maiorano

7

0 references

1

object named as

Giuseppe Viale

1 reference

Europe PubMed Central

18 August 2017

11

object named as

Patrick Neven

1 reference

Europe PubMed Central

18 August 2017

Aron Goldhirsch

20

object named as

Aron Goldhirsch

1 reference

Europe PubMed Central

18 August 2017

Meredith M Regan

3

object named as

Meredith M Regan

1 reference

Europe PubMed Central

18 August 2017

16

object named as

Karen N Price

1 reference

Europe PubMed Central

18 August 2017

Monica Castiglione-Gertsch

17

object named as

Monica Castiglione-Gertsch

1 reference

Europe PubMed Central

18 August 2017

Anita Giobbie-Hurder

2

object named as

Anita Giobbie-Hurder

1 reference

Europe PubMed Central

18 August 2017

Patrizia Dell'Orto

6

object named as

Patrizia Dell'Orto

1 reference

Europe PubMed Central

18 August 2017

12

object named as

Zsolt Orosz

1 reference

Europe PubMed Central

18 August 2017

Stephen G Braye

9

object named as

Stephen G Braye

1 reference

Europe PubMed Central

18 August 2017

Christian Ohlschlegel

10

object named as

Christian Ohlschlegel

1 reference

Europe PubMed Central

18 August 2017

Beat Thürlimann

15

object named as

Beat Thürlimann

1 reference

Europe PubMed Central

18 August 2017

author name string

Alan S Coates

4

1 reference

Europe PubMed Central

18 August 2017

Gaëtan MacGrogan

8

1 reference

Europe PubMed Central

18 August 2017

Fiona Knox

14

1 reference

Europe PubMed Central

18 August 2017

Richard D Gelber

18

1 reference

Europe PubMed Central

18 August 2017

Barry A Gusterson

19

1 reference

Europe PubMed Central

18 August 2017

Breast International Group Trial 1-98

21

1 reference

Europe PubMed Central

18 August 2017

language of work or name

0 references

publication date

3 November 2008

1 reference

Europe PubMed Central

18 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

18 August 2017

26

1 reference

Europe PubMed Central

18 August 2017

34

1 reference

Europe PubMed Central

18 August 2017

5569-5575

1 reference

Europe PubMed Central

18 August 2017

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

14 September 2017

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

14 September 2017

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

14 September 2017

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

14 September 2017

Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

14 September 2017

Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

14 September 2017

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

14 September 2017

Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

14 September 2017

Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

14 September 2017

A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

14 September 2017

MIB-1 labelling index is an independent prognostic marker in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

14 September 2017

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

14 September 2017

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

3 September 2018

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

3 September 2018

Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

3 September 2018

Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

3 September 2018

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

3 September 2018

Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

3 September 2018

Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651094

3 September 2018

Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count

1 reference

https://pubmed.ncbi.nlm.nih.gov/18981464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18981464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18981464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18981464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18981464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlations of cell cycle regulators (p53, p21, pRb and mdm2) and c-erbB-2 with biological markers of proliferation and overall survival in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18981464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18981464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

1 reference

https://pubmed.ncbi.nlm.nih.gov/18981464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18981464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2008.17.0829

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37117133&oldid=1962328337"